4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-042492
Co-Chief Executive Officer gave up 1,621 shares (to pay taxes)
- Co-Chief Executive Officer acquired 4,687 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MOHANTY ADITYA P. Co-Chief Executive Officer | 2018-07-10 | Option exercise | +4,687 | 103,005 | D | ||
| MOHANTY ADITYA P. Co-Chief Executive Officer | 2018-07-10 | Shares withheld for taxes | −1,621 | $2.20 | $3,566 | 101,384 | D |
| Derivatives | |||||||
| MOHANTY ADITYA P. Co-Chief Executive Officer | 2018-07-10 | Option exercise · Restricted Stock Units | −4,687 | 32,813 | D | ||
Loading xslF345X03/doc4.xml…